 | • レポートコード：MRC2-11QY11083 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバイオモニタリング・バイオバーデン試験のグローバル市場について調査・分析したレポートです。種類別（培地・試薬キット、機器、PCR（ポリメラーゼ連鎖反応）、自動微生物同定システム、顕微鏡、その他）市場規模、用途別（医療機器検査、製造工程モニタリング、環境モニタリング）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バイオモニタリング・バイオバーデン試験の競争状況、市場シェア ・世界のバイオモニタリング・バイオバーデン試験市場：種類別市場規模 2015年-2020年（培地・試薬キット、機器、PCR（ポリメラーゼ連鎖反応）、自動微生物同定システム、顕微鏡、その他） ・世界のバイオモニタリング・バイオバーデン試験市場：種類別市場規模予測 2021年-2026年（培地・試薬キット、機器、PCR（ポリメラーゼ連鎖反応）、自動微生物同定システム、顕微鏡、その他） ・世界のバイオモニタリング・バイオバーデン試験市場：用途別市場規模 2015年-2020年（医療機器検査、製造工程モニタリング、環境モニタリング） ・世界のバイオモニタリング・バイオバーデン試験市場：用途別市場規模予測 2021年-2026年（医療機器検査、製造工程モニタリング、環境モニタリング） ・北米のバイオモニタリング・バイオバーデン試験市場分析：米国、カナダ ・ヨーロッパのバイオモニタリング・バイオバーデン試験市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバイオモニタリング・バイオバーデン試験市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバイオモニタリング・バイオバーデン試験市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバイオモニタリング・バイオバーデン試験市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、STERIS Laboratories、Charles River Laboratories International、Lumex Instruments、Pacific BioLabs、Sigma-Aldrich、WuXi AppTec、Dynatec Labs、Nelson Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Biomonitoring is a simple process its of two type, the very first one is to check the toxic level before and after the project is completed and the other one is the proper checking of all the valid regulation and parameter for the project and maintained the guideline. Bioburden are refer as the number of bacteria present on the surface, the surface is not show sterilized. The present of bacteria on the surface can affect the industry like pharmaceutical and other industry which is directly related to the human begins. Various regulation has been made to check all the parameter of safety and cleaning in the industry or their products. For instance, in the U.S the Title 21 is the code of federal regulation that cover the drugs and food for FDA. Many other organization are also having the code and standard parameter for monitoring.
Biomonitoring and Bioburden testing market is a growing market, as there is growth in the pharmaceutical, biotechnology, medical devices, food industry and other industry every year and the guideline of the respective association are very strike for the industries. The product produce by this industry are directly or indirectly taken or affect the human. As the Centers for Disease Control and Prevention (U.S. Department of Health & Human Services) conduct by NBP (National Biomonitoring Program) which measure approx. 300 or more chemical and nutritional indicator in people. The costing and the approval process in various countries are the hindrance for this market.
Market Analysis and Insights: Global Biomonitoring and Bioburden Testing Market
The global Biomonitoring and Bioburden Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Biomonitoring and Bioburden Testing Scope and Market Size
Biomonitoring and Bioburden Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biomonitoring and Bioburden Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
STERIS Laboratories
Charles River Laboratories International
Lumex Instruments
Pacific BioLabs
Sigma-Aldrich
WuXi AppTec
Dynatec Labs
Nelson Laboratories
Market segment by Type, the product can be split into
Culture Media and Reagents Kit
Instruments
PCR (Polymerase Chain Reaction)
Automated Microbial Identification Systems
Microscope
Others
Market segment by Application, split into
Medical Devices Testing
Monitoring of Manufacturing Process
Environmental Monitoring
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biomonitoring and Bioburden Testing Revenue
1.4 Market by Type
1.4.1 Global Biomonitoring and Bioburden Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Culture Media and Reagents Kit
1.4.3 Instruments
1.4.4 PCR (Polymerase Chain Reaction)
1.4.5 Automated Microbial Identification Systems
1.4.6 Microscope
1.4.7 Others
1.5 Market by Application
1.5.1 Global Biomonitoring and Bioburden Testing Market Share by Application: 2020 VS 2026
1.5.2 Medical Devices Testing
1.5.3 Monitoring of Manufacturing Process
1.5.4 Environmental Monitoring
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Biomonitoring and Bioburden Testing Market Perspective (2015-2026)
2.2 Global Biomonitoring and Bioburden Testing Growth Trends by Regions
2.2.1 Biomonitoring and Bioburden Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biomonitoring and Bioburden Testing Historic Market Share by Regions (2015-2020)
2.2.3 Biomonitoring and Bioburden Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biomonitoring and Bioburden Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Biomonitoring and Bioburden Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biomonitoring and Bioburden Testing Players by Market Size
3.1.1 Global Top Biomonitoring and Bioburden Testing Players by Revenue (2015-2020)
3.1.2 Global Biomonitoring and Bioburden Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Biomonitoring and Bioburden Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biomonitoring and Bioburden Testing Market Concentration Ratio
3.2.1 Global Biomonitoring and Bioburden Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biomonitoring and Bioburden Testing Revenue in 2019
3.3 Biomonitoring and Bioburden Testing Key Players Head office and Area Served
3.4 Key Players Biomonitoring and Bioburden Testing Product Solution and Service
3.5 Date of Enter into Biomonitoring and Bioburden Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biomonitoring and Bioburden Testing Historic Market Size by Type (2015-2020)
4.2 Global Biomonitoring and Bioburden Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
5.2 Global Biomonitoring and Bioburden Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biomonitoring and Bioburden Testing Market Size (2015-2020)
6.2 Biomonitoring and Bioburden Testing Key Players in North America (2019-2020)
6.3 North America Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
6.4 North America Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biomonitoring and Bioburden Testing Market Size (2015-2020)
7.2 Biomonitoring and Bioburden Testing Key Players in Europe (2019-2020)
7.3 Europe Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
7.4 Europe Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
8 China
8.1 China Biomonitoring and Bioburden Testing Market Size (2015-2020)
8.2 Biomonitoring and Bioburden Testing Key Players in China (2019-2020)
8.3 China Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
8.4 China Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biomonitoring and Bioburden Testing Market Size (2015-2020)
9.2 Biomonitoring and Bioburden Testing Key Players in Japan (2019-2020)
9.3 Japan Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
9.4 Japan Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biomonitoring and Bioburden Testing Market Size (2015-2020)
10.2 Biomonitoring and Bioburden Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
11 India
11.1 India Biomonitoring and Bioburden Testing Market Size (2015-2020)
11.2 Biomonitoring and Bioburden Testing Key Players in India (2019-2020)
11.3 India Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
11.4 India Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biomonitoring and Bioburden Testing Market Size (2015-2020)
12.2 Biomonitoring and Bioburden Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Biomonitoring and Bioburden Testing Market Size by Type (2015-2020)
12.4 Central & South America Biomonitoring and Bioburden Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Biomonitoring and Bioburden Testing Introduction
13.1.4 Merck Revenue in Biomonitoring and Bioburden Testing Business (2015-2020))
13.1.5 Merck Recent Development
13.2 STERIS Laboratories
13.2.1 STERIS Laboratories Company Details
13.2.2 STERIS Laboratories Business Overview
13.2.3 STERIS Laboratories Biomonitoring and Bioburden Testing Introduction
13.2.4 STERIS Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
13.2.5 STERIS Laboratories Recent Development
13.3 Charles River Laboratories International
13.3.1 Charles River Laboratories International Company Details
13.3.2 Charles River Laboratories International Business Overview
13.3.3 Charles River Laboratories International Biomonitoring and Bioburden Testing Introduction
13.3.4 Charles River Laboratories International Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
13.3.5 Charles River Laboratories International Recent Development
13.4 Lumex Instruments
13.4.1 Lumex Instruments Company Details
13.4.2 Lumex Instruments Business Overview
13.4.3 Lumex Instruments Biomonitoring and Bioburden Testing Introduction
13.4.4 Lumex Instruments Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
13.4.5 Lumex Instruments Recent Development
13.5 Pacific BioLabs
13.5.1 Pacific BioLabs Company Details
13.5.2 Pacific BioLabs Business Overview
13.5.3 Pacific BioLabs Biomonitoring and Bioburden Testing Introduction
13.5.4 Pacific BioLabs Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
13.5.5 Pacific BioLabs Recent Development
13.6 Sigma-Aldrich
13.6.1 Sigma-Aldrich Company Details
13.6.2 Sigma-Aldrich Business Overview
13.6.3 Sigma-Aldrich Biomonitoring and Bioburden Testing Introduction
13.6.4 Sigma-Aldrich Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
13.6.5 Sigma-Aldrich Recent Development
13.7 WuXi AppTec
13.7.1 WuXi AppTec Company Details
13.7.2 WuXi AppTec Business Overview
13.7.3 WuXi AppTec Biomonitoring and Bioburden Testing Introduction
13.7.4 WuXi AppTec Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
13.7.5 WuXi AppTec Recent Development
13.8 Dynatec Labs
13.8.1 Dynatec Labs Company Details
13.8.2 Dynatec Labs Business Overview
13.8.3 Dynatec Labs Biomonitoring and Bioburden Testing Introduction
13.8.4 Dynatec Labs Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
13.8.5 Dynatec Labs Recent Development
13.9 Nelson Laboratories
13.9.1 Nelson Laboratories Company Details
13.9.2 Nelson Laboratories Business Overview
13.9.3 Nelson Laboratories Biomonitoring and Bioburden Testing Introduction
13.9.4 Nelson Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2015-2020)
13.9.5 Nelson Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Biomonitoring and Bioburden Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Biomonitoring and Bioburden Testing Revenue
Table 3. Ranking of Global Top Biomonitoring and Bioburden Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biomonitoring and Bioburden Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Culture Media and Reagents Kit
Table 6. Key Players of Instruments
Table 7. Key Players of PCR (Polymerase Chain Reaction)
Table 8. Key Players of Automated Microbial Identification Systems
Table 9. Key Players of Microscope
Table 10. Key Players of Others
Table 11. Global Biomonitoring and Bioburden Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Biomonitoring and Bioburden Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Biomonitoring and Bioburden Testing Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Biomonitoring and Bioburden Testing Market Share by Regions (2015-2020)
Table 15. Global Biomonitoring and Bioburden Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Biomonitoring and Bioburden Testing Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Biomonitoring and Bioburden Testing Market Growth Strategy
Table 21. Main Points Interviewed from Key Biomonitoring and Bioburden Testing Players
Table 22. Global Biomonitoring and Bioburden Testing Revenue by Players (2015-2020) (Million US$)
Table 23. Global Biomonitoring and Bioburden Testing Market Share by Players (2015-2020)
Table 24. Global Top Biomonitoring and Bioburden Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomonitoring and Bioburden Testing as of 2019)
Table 25. Global Biomonitoring and Bioburden Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Biomonitoring and Bioburden Testing Product Solution and Service
Table 28. Date of Enter into Biomonitoring and Bioburden Testing Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Biomonitoring and Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 31. Global Biomonitoring and Bioburden Testing Market Size Share by Type (2015-2020)
Table 32. Global Biomonitoring and Bioburden Testing Revenue Market Share by Type (2021-2026)
Table 33. Global Biomonitoring and Bioburden Testing Market Size Share by Application (2015-2020)
Table 34. Global Biomonitoring and Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 35. Global Biomonitoring and Bioburden Testing Market Size Share by Application (2021-2026)
Table 36. North America Key Players Biomonitoring and Bioburden Testing Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Biomonitoring and Bioburden Testing Market Share (2019-2020)
Table 38. North America Biomonitoring and Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 39. North America Biomonitoring and Bioburden Testing Market Share by Type (2015-2020)
Table 40. North America Biomonitoring and Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 41. North America Biomonitoring and Bioburden Testing Market Share by Application (2015-2020)
Table 42. Europe Key Players Biomonitoring and Bioburden Testing Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Biomonitoring and Bioburden Testing Market Share (2019-2020)
Table 44. Europe Biomonitoring and Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Biomonitoring and Bioburden Testing Market Share by Type (2015-2020)
Table 46. Europe Biomonitoring and Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Biomonitoring and Bioburden Testing Market Share by Application (2015-2020)
Table 48. China Key Players Biomonitoring and Bioburden Testing Revenue (2019-2020) (Million US$)
Table 49. China Key Players Biomonitoring and Bioburden Testing Market Share (2019-2020)
Table 50. China Biomonitoring and Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 51. China Biomonitoring and Bioburden Testing Market Share by Type (2015-2020)
Table 52. China Biomonitoring and Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 53. China Biomonitoring and Bioburden Testing Market Share by Application (2015-2020)
Table 54. Japan Key Players Biomonitoring and Bioburden Testing Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Biomonitoring and Bioburden Testing Market Share (2019-2020)
Table 56. Japan Biomonitoring and Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Biomonitoring and Bioburden Testing Market Share by Type (2015-2020)
Table 58. Japan Biomonitoring and Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Biomonitoring and Bioburden Testing Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Biomonitoring and Bioburden Testing Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Biomonitoring and Bioburden Testing Market Share (2019-2020)
Table 62. Southeast Asia Biomonitoring and Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Biomonitoring and Bioburden Testing Market Share by Type (2015-2020)
Table 64. Southeast Asia Biomonitoring and Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Biomonitoring and Bioburden Testing Market Share by Application (2015-2020)
Table 66. India Key Players Biomonitoring and Bioburden Testing Revenue (2019-2020) (Million US$)
Table 67. India Key Players Biomonitoring and Bioburden Testing Market Share (2019-2020)
Table 68. India Biomonitoring and Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 69. India Biomonitoring and Bioburden Testing Market Share by Type (2015-2020)
Table 70. India Biomonitoring and Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 71. India Biomonitoring and Bioburden Testing Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Biomonitoring and Bioburden Testing Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Biomonitoring and Bioburden Testing Market Share (2019-2020)
Table 74. Central & South America Biomonitoring and Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Biomonitoring and Bioburden Testing Market Share by Type (2015-2020)
Table 76. Central & South America Biomonitoring and Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Biomonitoring and Bioburden Testing Market Share by Application (2015-2020)
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Product
Table 81. Merck Revenue in Biomonitoring and Bioburden Testing Business (2015-2020) (Million US$)
Table 82. Merck Recent Development
Table 83. STERIS Laboratories Company Details
Table 84. STERIS Laboratories Business Overview
Table 85. STERIS Laboratories Product
Table 86. STERIS Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2015-2020) (Million US$)
Table 87. STERIS Laboratories Recent Development
Table 88. Charles River Laboratories International Company Details
Table 89. Charles River Laboratories International Business Overview
Table 90. Charles River Laboratories International Product
Table 91. Charles River Laboratories International Revenue in Biomonitoring and Bioburden Testing Business (2015-2020) (Million US$)
Table 92. Charles River Laboratories International Recent Development
Table 93. Lumex Instruments Company Details
Table 94. Lumex Instruments Business Overview
Table 95. Lumex Instruments Product
Table 96. Lumex Instruments Revenue in Biomonitoring and Bioburden Testing Business (2015-2020) (Million US$)
Table 97. Lumex Instruments Recent Development
Table 98. Pacific BioLabs Company Details
Table 99. Pacific BioLabs Business Overview
Table 100. Pacific BioLabs Product
Table 101. Pacific BioLabs Revenue in Biomonitoring and Bioburden Testing Business (2015-2020) (Million US$)
Table 102. Pacific BioLabs Recent Development
Table 103. Sigma-Aldrich Company Details
Table 104. Sigma-Aldrich Business Overview
Table 105. Sigma-Aldrich Product
Table 106. Sigma-Aldrich Revenue in Biomonitoring and Bioburden Testing Business (2015-2020) (Million US$)
Table 107. Sigma-Aldrich Recent Development
Table 108. WuXi AppTec Company Details
Table 109. WuXi AppTec Business Overview
Table 110. WuXi AppTec Product
Table 111. WuXi AppTec Revenue in Biomonitoring and Bioburden Testing Business (2015-2020) (Million US$)
Table 112. WuXi AppTec Recent Development
Table 113. Dynatec Labs Business Overview
Table 114. Dynatec Labs Product
Table 115. Dynatec Labs Company Details
Table 116. Dynatec Labs Revenue in Biomonitoring and Bioburden Testing Business (2015-2020) (Million US$)
Table 117. Dynatec Labs Recent Development
Table 118. Nelson Laboratories Company Details
Table 119. Nelson Laboratories Business Overview
Table 120. Nelson Laboratories Product
Table 121. Nelson Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2015-2020) (Million US$)
Table 122. Nelson Laboratories Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biomonitoring and Bioburden Testing Market Share by Type: 2020 VS 2026
Figure 2. Culture Media and Reagents Kit Features
Figure 3. Instruments Features
Figure 4. PCR (Polymerase Chain Reaction) Features
Figure 5. Automated Microbial Identification Systems Features
Figure 6. Microscope Features
Figure 7. Others Features
Figure 8. Global Biomonitoring and Bioburden Testing Market Share by Application: 2020 VS 2026
Figure 9. Medical Devices Testing Case Studies
Figure 10. Monitoring of Manufacturing Process Case Studies
Figure 11. Environmental Monitoring Case Studies
Figure 12. Biomonitoring and Bioburden Testing Report Years Considered
Figure 13. Global Biomonitoring and Bioburden Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Biomonitoring and Bioburden Testing Market Share by Regions: 2020 VS 2026
Figure 15. Global Biomonitoring and Bioburden Testing Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Biomonitoring and Bioburden Testing Market Share by Players in 2019
Figure 18. Global Top Biomonitoring and Bioburden Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomonitoring and Bioburden Testing as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Biomonitoring and Bioburden Testing Revenue in 2019
Figure 20. North America Biomonitoring and Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Biomonitoring and Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Biomonitoring and Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Biomonitoring and Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Biomonitoring and Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Biomonitoring and Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Biomonitoring and Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
バイオバーデン試験の世界市場（～2026年） Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and effectiveness of medical devices. Market Analysis and Insights: Global Bioburden Testing Mark…- 自動抗菌薬感受性検査（AST）の世界市場（～2026年） Automated antimicrobial susceptibility testing is extensively used to achieve minimum inhibitory concentration (MIC) results using an antimicrobial susceptibility testing system, which offers flexible, customizable testing options to accommodate laboratories of all sizes. Antimicrobial susceptibilit…
- 自動微生物検査の世界市場（～2026年） Market Analysis and Insights: Global Automated Microbiology Testing Market The global Automated Microbiology Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Automated Microbiology Testing Scope and Market Size …
- 血清培地・試薬-細胞培養の世界市場（～2026年） Cell culture is the process by which cells are grown under controlled conditions, generally outside their natural environment. After the cells of interest have been isolated from living tissue, they can subsequently be maintained under carefully controlled conditions. These conditions vary for each …
- 流行性耳下腺炎ウイルス検査の世界市場（～2026年） Mumps is a contagious disease which affects children as well as adult and it is caused by the mumps virus. Mumps is a type of viral infection that affects the parotid gland which one of the member of saliva producing gland. The swelling in one or both parotid gland is the indication for the mumps. T…